Alzeca Biosciences Overview

  • Founded
  • 2010

Founded
  • Status
  • Private

  • Employees
  • 4

Employees
  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $11M

  • Investors
  • 4

Alzeca Biosciences General Information

Description

Developer of advanced imaging agents designed for the diagnosis of Alzheimer's disease and other neurodegenerative disorders. The company's agents are based on nanoparticles that specifically bind to abnormal proteins that accumulate in the brain years before significant cognitive symptoms appear, enabling healthcare providers to easily detect and screen for disorders at a lower cost.

Contact Information

Website
www.alzeca.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 1800 Bering Drive
  • Suite 850
  • Houston, TX 77057
  • United States
+1 (216) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alzeca Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 17-Aug-2017 $11M 000.00 0000 Completed Clinical Trials - Phase 1
2. Early Stage VC 30-Nov-2012 00000 000.00 Completed Startup
1. Early Stage VC $11M $11M 0000 Completed Startup
To view Alzeca Biosciences’s complete valuation and funding history, request access »

Alzeca Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Alzeca Biosciences’s complete cap table history, request access »

Alzeca Biosciences Executive Team (6)

Name Title Board Seat Contact Info
Carlo Medici Ph.D Chief Executive Officer & Board Member
Jason Eriksen Ph.D Co-Founder & Chairman of Scientific Advisory Board
Ananth Annapragada Ph.D Co-Founder, Board Member & Scientific Advisor
Peter Working Ph.D Scientific Advisor
You’re viewing 4 of 6 executive team members. Get the full list »

Alzeca Biosciences Board Members (10)

Name Representing Role Since
Ananth Annapragada Ph.D Self Co-Founder, Board Member & Scientific Advisor 000 0000
Carlo Medici Ph.D Alzeca Biosciences Chief Executive Officer & Board Member 000 0000
Jason Eriksen Ph.D Self Co-Founder & Chairman of Scientific Advisory Board 000 0000
Navneet Puri Ph.D Self Board Member 000 0000
Peter Werth Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Alzeca Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alzeca Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Werth Ventures Family Office Minority 000 0000 000000 0
Central Texas Angel Network Angel Group Minority 000 0000 000000 0
Dolby Family Ventures Venture Capital Minority 000 0000 000000 0
Fieldstone Partners Merchant Banking Firm Minority 000 0000 000000 0
To view Alzeca Biosciences’s complete investors history, request access »